“Should Anti-CGRP Monoclonal Antibodies Always Be the Drug of First Choice for Migraine Prophylaxis in Brazil? – a Pharmacoeconomic Study”. Headache Medicine 15, no. Supplement (August 15, 2024): 98. Accessed January 22, 2026. https://headachemedicine.com.br/hm/article/view/1230.